Clinical Report: A Greener Route to Anti-Doping Analysis
Overview
A validated bar adsorptive microextraction (BAµE) workflow offers a lower-solvent alternative for confirming cocaine and its metabolites in urine. This method meets World Anti-Doping Agency (WADA) criteria, demonstrating no false positives or negatives.
Background
Cocaine is a commonly detected substance in anti-doping tests, but its low concentration in urine complicates confirmatory analysis. Effective sample preparation is crucial to concentrate target analytes and minimize interference from endogenous compounds.
Data Highlights
| Parameter | Value |
|---|---|
| Limit of identification for cocaine | 1.0 ng/mL |
| Extraction volume of acetonitrile | 150 µL |
| Stability of final extracts | Up to 144 hours |
Key Findings
- The BAµE method showed no false positives in blank urine samples.
- No false negatives were observed in spiked samples.
- Validation was conducted against WADA criteria, confirming compliance.
- The method improved selectivity and sensitivity compared to traditional solid-phase extraction/GC-MS methods.
- The workflow is suitable for confirmatory testing rather than high-throughput screening.
Clinical Implications
The BAµE method complies with WADA standards for confirmatory testing of cocaine and its metabolites.
Conclusion
The BAµE workflow provides a lower-solvent alternative for anti-doping analysis.
Related Resources & Content
- Bar adsorptive microextraction for the qualitative detection of cocaine and its metabolites in urine for anti-doping control, Scientific Reports, 2026 -- Title
- Prohibited List | World Anti Doping Agency -- Title
- WADA Technical Document – TD2022MRPL -- Title
- WADA Technical Document – TD2023IDCR -- Title
- the analytical scientist — Holding the Line: Sitting Down With Mario Thevis
- Archives of Toxicology — Advancements in High-Resolution Mass Spectrometry for Analyzing New Psychoactive Substances
- the medicine maker — Trends and Challenges in Nitrosamine Testing Part Four The Regulatory Landscape
- the medicine maker — Trends and Challenges in Nitrosamine Testing: Part Three – Building a Method
- Substances of Abuse 101 | USADA
- Prohibited List | World Anti Doping Agency
- WADA Technical Document – TD2022MRPL
- Manual Reporting of Prohibited Substance(s) and/or Metabolite(s) of Prohibited Substance(s) Associated with an Adverse Analytical Finding (AAF) in the Lab Results [1] – ADAMS Help Center
- wadaWADA Technical Document – TD2023IDCR